Arch Biopartners Arranges CAD 900,000 Private Placement

Bitget2026/11/06 12:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Arch Biopartners arranged a non-brokered private placement of 1,058,823 common shares at CAD 0.85 each to raise CAD 900,000.
Proceeds will fund U.S. site onboarding for the Phase II LSALT peptide trial targeting cardiac surgery-associated acute kidney injury.
Funds will also support IL-32 chronic kidney disease preclinical studies, marketing and working capital.
An officer will subscribe for 729,411 common shares in the offering.
Closing is expected around November 12, 2026, subject to regulatory approvals and customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arch Biopartners Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611060720PRIMZONEFULLFEED9872040) on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Arch Biopartners Arranges CAD 900,000 Private Placement

You may also like

Crypto prices